Correlation Between Changzhou Evergreen and Innovative Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Changzhou Evergreen and Innovative Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Changzhou Evergreen and Innovative Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Changzhou Evergreen Technology and Innovative Medical Management, you can compare the effects of market volatilities on Changzhou Evergreen and Innovative Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Changzhou Evergreen with a short position of Innovative Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Changzhou Evergreen and Innovative Medical.

Diversification Opportunities for Changzhou Evergreen and Innovative Medical

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Changzhou and Innovative is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Changzhou Evergreen Technology and Innovative Medical Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovative Medical and Changzhou Evergreen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Changzhou Evergreen Technology are associated (or correlated) with Innovative Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovative Medical has no effect on the direction of Changzhou Evergreen i.e., Changzhou Evergreen and Innovative Medical go up and down completely randomly.

Pair Corralation between Changzhou Evergreen and Innovative Medical

Assuming the 90 days trading horizon Changzhou Evergreen Technology is expected to generate 0.69 times more return on investment than Innovative Medical. However, Changzhou Evergreen Technology is 1.45 times less risky than Innovative Medical. It trades about 0.15 of its potential returns per unit of risk. Innovative Medical Management is currently generating about 0.05 per unit of risk. If you would invest  1,640  in Changzhou Evergreen Technology on August 30, 2024 and sell it today you would earn a total of  170.00  from holding Changzhou Evergreen Technology or generate 10.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Changzhou Evergreen Technology  vs.  Innovative Medical Management

 Performance 
       Timeline  
Changzhou Evergreen 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Changzhou Evergreen Technology are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Changzhou Evergreen sustained solid returns over the last few months and may actually be approaching a breakup point.
Innovative Medical 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical sustained solid returns over the last few months and may actually be approaching a breakup point.

Changzhou Evergreen and Innovative Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Changzhou Evergreen and Innovative Medical

The main advantage of trading using opposite Changzhou Evergreen and Innovative Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Changzhou Evergreen position performs unexpectedly, Innovative Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovative Medical will offset losses from the drop in Innovative Medical's long position.
The idea behind Changzhou Evergreen Technology and Innovative Medical Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance